Edwards Lifesciences Securities Settlement

This proposed securities class action settlement concerns people or entities who bought or otherwise acquired Edwards common stock during the stated class period and were damaged. Eligible class members must submit a supported claim to seek a share of the net fund. The Court has preliminarily approved the proposed settlement, but must still decide whether to grant final approval.

Edwards Lifesciences Securities Settlement

Benefit Summary

Eligible class members: available benefits include Pro rata payment based on recognized loss.

Payments come from the $39,000,000 settlement fund and may change after approved deductions.

Available Awards

Pro rata payment based on recognized loss

Who Is Included

You may be included if you purchased or otherwise acquired Edwards common stock from February 6, 2024 through July 24, 2024, inclusive, and were damaged. Important exclusions apply to the defendants, certain related people and entities, and people or entities whose exclusion requests the Court accepts.

  • Products included: Edwards Lifesciences Corporation common stock
  • Purchase window: February 6, 2024 through July 24, 2024, inclusive
  • Proof required: To receive a payment, you must submit a Claim Form with adequate supporting documentation. The notice says to retain records of your ownership of and transactions in Edwards common stock because they may be needed to document the claim.

Claim and Payment Information

  • Claim method: Submit online or mail a Claim Form; mailed forms must be postmarked by the deadline.
  • Claim deadline: 2026-12-02
  • Instructions: Complete a Claim Form and provide adequate documentation of your Edwards common-stock ownership and transactions. You can obtain the form from the settlement website or request one from the Claims Administrator. Keep your transaction records, as they may be needed to support your claim.

Questions & Answers

What is the estimated recovery per share?

The notice gives an overall estimate before court-approved deductions. A person’s payment depends on the allocation formula, documented transactions, recognized loss, and the total value of valid claims.

  • The notice estimates an average recovery of about $0.66 per eligible share before court-approved fees, expenses, taxes, and administration costs.
  • This is only an overall estimate, not a promised payment. Your amount can be higher or lower based on your trading history and the total value of valid claims.

Can I claim shares held through an Edwards ERISA retirement or benefit plan?

Do not list shares held through an ERISA-covered Edwards employee benefit plan on this claim.

  • Shares held through an Edwards employee benefit plan covered by ERISA should not be included on your claim form.
  • You may include only Edwards shares you bought or acquired outside that ERISA plan.

What if I traded options or acquired common stock by exercising an option?

The settlement covers Edwards common stock, not option contracts.

  • Options themselves are not eligible for a payment.
  • If you bought or sold Edwards common stock by exercising an option, the stock transaction may be considered. The relevant date is the option exercise date, and the price is the exercise price.

Which transactions receive no recognized loss under the proposed plan?

The proposed plan does not treat every Class Period transaction as producing a recognized loss.

  • A share sold before the close of trading on July 24, 2024 has a recognized loss amount of $0 under the proposed allocation plan.
  • Short sales and purchases used to cover short sales also have a recognized loss amount of $0.

How are multiple purchases and sales matched when my claim is calculated?

This matching method can affect how the administrator calculates a claim.

  • All purchases and sales from February 6, 2024 through October 22, 2024 are matched using “last in, first out” (LIFO).
  • That means sales are first matched to the most recent earlier purchases, working backward, before any shares owned at the start of the Class Period are used.

What records should I keep for my claim?

The specific documentation standards are not provided in this notice.

  • The notice requires adequate supporting documentation but does not list the exact documents required for a payment claim.
  • Keep all records showing your ownership of and transactions in Edwards common stock. The notice says the parties and Claims Administrator do not have your transaction information.

What do I need to do if I want to exclude myself?

Leaving the settlement is also called opting out. It preserves your ability to pursue your own related claim, but it gives up any payment from this settlement.

  • To leave the settlement, mail a written Request for Exclusion so it is received by December 2, 2026.
  • The request must give your contact information, state that you request exclusion in this case, list specified share holdings and Class Period transactions, and be signed.
  • If you exclude yourself, you cannot receive money from this settlement.

Could there be another payment after the first distribution?

A later payment is possible, but it is not guaranteed.

  • If the first payment is made and money remains six months later, the administrator may make another distribution if Lead Counsel and the Claims Administrator decide it is cost-effective.
  • Later distributions go only to authorized claimants who cashed their earlier payment and would receive at least $10 more.

Other Important Dates

  • Exclusion deadline: 2026-12-02
  • Objection deadline: 2026-12-02
  • Final approval hearing: December 16, 2026, at 1:30 p.m. Pacific Time
  • Hearing location: Courtroom 9C, 9th Floor of the Felicitas and Gonzalo Mendez United States Courthouse, 350 W 1st Street, Los Angeles, CA 90012

Case Details

  • Total settlement fund: $39,000,000
  • Case name: Patel v. Edwards Lifesciences Corp.
  • Case number: 8:24-cv-02221-AH-KES
  • Court: United States District Court for the Central District of California
  • Administrator: Kroll Settlement Administration
  • Official Settlement Website: https://www.EdwardsLifesciencesSecuritiesLitigation.com

Sources

Official Settlement Website
Claim form, FAQ, deadlines, administrator information
Visit Site →
Official Settlement Notice (PDF)
Court-approved notice describing eligibility and benefits
Open PDF →

Official Notice

Read the notice PDF or the text version below.

Official Notice PDF
Some phones don’t display PDFs inside the page. Use the button below to open it.
Open PDF
Select this tab to load the official notice text.
Information last updated on 2026-09-26